Publications by authors named "Billy Franks"

24Publications

Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive Bladder.

Epidemiology 2019 03;30(2):e8-e9

RTI Health Solutions, Barcelona, Spain, RTI Health Solutions, Waltham, MA RTI Health Solutions, Research Triangle Park, NC RTI Health Solutions, Barcelona, Spain RTI Health Solutions, Research Triangle Park, NC Astellas Pharma B.V., Leiden, The Netherlands RTI Health Solutions, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000953DOI Listing
March 2019

Cardiovascular safety of mirabegron: analysis of an integrated clinical trial database of patients with overactive bladder syndrome.

J Am Soc Hypertens 2018 11 10;12(11):768-778.e1. Epub 2018 Aug 10.

Astellas Pharma Global Development, Inc., Northbrook, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jash.2018.08.001DOI Listing
November 2018

Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant.

J Med Econ 2018 Nov 14;21(11):1067-1074. Epub 2018 Aug 14.

e Medical Affairs , Astellas Pharma Global Development, Inc. , Northbrook , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2018.1503596DOI Listing
November 2018

Value of Free-text Comments for Validating Cancer Cases Using Primary-care Data in the United Kingdom.

Epidemiology 2018 09;29(5):e41-e42

RTI Health Solutions, Barcelona, Spain RTI Health Solutions, Waltham, MA RTI Health Solutions, RTP, Research Triangle Park, NC RTI Health Solutions, Barcelona, Spain RTI Health Solutions, RTP, Research Triangle Park, NC Astellas Pharma B.V., Leiden, The Netherlands RTI Health Solutions, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000856DOI Listing
September 2018

Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.

Can J Urol 2015 Aug;22(4):7914-23

Department of Surgery, Division of Urology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
August 2015

Efficacy outcomes by baseline prostate-specific antigen quartile in the AFFIRM trial.

Eur Urol 2015 Feb 27;67(2):223-30. Epub 2014 Aug 27.

Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2014.08.025DOI Listing
February 2015

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.

Mycoses 2014 Nov 18;57(11):652-8. Epub 2014 Jun 18.

David Horn LLC, Doylestown, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12212DOI Listing
November 2014

Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.

Mycoses 2014 Apr 22;57(4):240-6. Epub 2013 Oct 22.

Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12149DOI Listing
April 2014

Differences in heart rate response to adenosine and regadenoson in patients with and without diabetes mellitus.

Am Heart J 2009 Apr 6;157(4):771-6. Epub 2009 Mar 6.

Department of Medicine, University of Alabama at Birmingham, 35294-0006, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2009.01.011DOI Listing
April 2009

Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis.

J Am Acad Dermatol 2008 Jan 12;58(1):116-24. Epub 2007 Nov 12.

Baylor Research Institute, Dallas, Texas 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2007.09.030DOI Listing
January 2008